CIWT yields 500000.00% · JNJ yields 2.14%● Live data
📍 CIWT pulled ahead of the other in Year 1
Combined, CIWT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CIWT + JNJ for your $10,000?
China Industrial Waste Management, Inc. provides environmental services and solutions in northeastern China. The company collects, stores, treats, disposes, and recycles industrial solid waste through incineration and/or landfill, physical and/or chemical treatment, material processing, packaging, analysis, and storage. It is also involved in the treatment of municipal sewage, as well as sludge resulting from the processing of sewage that is routed from the sewage treatment facilities located in Dalian and surrounding areas. The company operates a sewage treatment facility and a sludge treatment facility in Dalian, as well as provides environmental pollution remediation services to the Dalian municipal government. In addition, it offers environmental protection, technology consultation, pollution treatment, waste management design processing, waste disposal, waste transportation, and onsite waste management services. The company sells its recycled materials, including cupric sulfate, as well as metals and methane derived from sludge treatment to commodity traders and metallurgical companies. China Industrial Waste Management, Inc. was founded in 1991 and is based in Dalian, China.
Full CIWT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.